Author | L. G. Mellbin, MD


Glucose-lowering treatment impacts prognosis in diabetic patients after MI: Post hoc analysis of the DIGAMI 2 trial

December 08, 2008

We conducted a post hoc analysis of the DIGAMI 2 (Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction 2) trial to assess the impact of glucose-lowering treatment in 1181 diabetic patients who were discharged from the hospital after experiencing a myocardial infarction (MI).